Jack In The Box (JACK) came out with quarterly earnings of $0.3 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $1.16 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -34.78%. A quarter ago, it was expected that this burger chain would post earnings of $1.16 per share when it actually produced earnings of $1.02, delivering a surprise of -12.07%.Over the last four quarters, the co ...

Core Insights - Freightos Limited reported a quarterly loss of $0.1 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.08, marking an earnings surprise of -25.00% [1] - The company generated revenues of $7.67 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 0.36%, but showing an increase from $6.18 million year-over-year [2] - Freightos Limited's stock has increased by approximately 24.9% since the beginning of the year, outperforming the S&P 500's gain of 14.5% [3] Financial Performance - Over the last four quarters, Freightos Limited has surpassed consensus EPS estimates only once [2] - The current consensus EPS estimate for the upcoming quarter is -$0.08 on revenues of $7.7 million, and for the current fiscal year, it is -$0.33 on revenues of $29.8 million [7] Market Outlook - The company's earnings outlook will be crucial for future stock performance, with mixed trends in estimate revisions noted prior to the earnings release [4][6] - The Zacks Rank for Freightos Limited is currently 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Financial Transaction Services industry, to which Freightos Limited belongs, is currently ranked in the bottom 39% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Another company in the same industry, Nayax, is expected to report significant earnings growth, with a projected EPS of $0.21, reflecting a year-over-year change of +950% [9]

Core Insights - Research Solutions Inc. (RSSS) reported quarterly earnings of $0.03 per share, matching the Zacks Consensus Estimate, and showing an increase from $0.02 per share a year ago [1] - The company posted revenues of $12.31 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 0.26% and up from $12.04 million year-over-year [2] - Research Solutions shares have declined approximately 26% since the beginning of the year, contrasting with the S&P 500's gain of 16.5% [3] Earnings Performance - The company had a surprise of +75% in the previous quarter, reporting earnings of $0.07 per share against an expected $0.04 [1] - Over the last four quarters, Research Solutions has surpassed consensus EPS estimates only once [1] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.03 on revenues of $12.43 million, and for the current fiscal year, it is $0.14 on revenues of $51.02 million [7] - The estimate revisions trend for Research Solutions was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Commercial Printing industry, to which Research Solutions belongs, is currently ranked in the bottom 18% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact investor sentiment [5]

Core Insights - Flux Power Holdings, Inc. reported a quarterly loss of $0.14 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.04, marking an earnings surprise of -250.00% [1] - The company's revenues for the quarter ended September 2025 were $13.18 million, missing the Zacks Consensus Estimate by 20.1%, and down from $16.13 million a year ago [2] - The stock has increased approximately 50% since the beginning of the year, outperforming the S&P 500's gain of 16.5% [3] Financial Performance - Over the last four quarters, Flux Power has surpassed consensus EPS estimates only once [2] - The current consensus EPS estimate for the upcoming quarter is -$0.04 on revenues of $17.59 million, and for the current fiscal year, it is -$0.03 on revenues of $73.08 million [7] Market Outlook - The company's earnings outlook will be crucial for future stock performance, with management's commentary on the earnings call being a key factor [4] - The Zacks Rank for Flux Power is currently 2 (Buy), indicating expectations for the stock to outperform the market in the near future [6] - The Electronics - Miscellaneous Products industry, to which Flux Power belongs, is currently in the top 14% of Zacks industries, suggesting a favorable industry outlook [8]

Core Insights - RenovoRx, Inc. reported a quarterly loss of $0.08 per share, consistent with the Zacks Consensus Estimate, compared to a loss of $0.10 per share a year ago [1] - The company generated revenues of $0.27 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 35.12%, while revenues were zero a year ago [2] - RenovoRx shares have declined approximately 22.5% year-to-date, contrasting with the S&P 500's gain of 16.5% [3] Company Performance - The earnings outlook for RenovoRx is mixed, with the current consensus EPS estimate for the upcoming quarter at -$0.08 on revenues of $0.48 million, and -$0.31 on revenues of $1.51 million for the current fiscal year [7] - The company has surpassed consensus EPS estimates only once in the last four quarters [1] Industry Context - The Medical - Biomedical and Genetics industry, to which RenovoRx belongs, is currently ranked in the top 35% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact RenovoRx's stock performance [5]

Bitfarms Ltd. (BITF) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.09 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this company would post a loss of $0.01 per share when it actually produced a loss of $0.02, delivering a surprise of -100%.Over the last four quarters, the company has surpassed consensus EPS estimates just once.Bitfarms, which belongs to the Zacks Techn ...

Core Insights - Anterix reported a quarterly loss of $0.14 per share, significantly better than the Zacks Consensus Estimate of a loss of $0.65, marking an earnings surprise of +78.46% [1] - The company achieved revenues of $1.55 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 9.30% [2] - Anterix has consistently surpassed consensus EPS estimates over the last four quarters, achieving this four times [2] Financial Performance - The loss per share improved from $0.69 a year ago to $0.14 this quarter, indicating a positive trend in financial performance [1] - The company has topped consensus revenue estimates only once in the last four quarters, despite the recent positive revenue report [2] Stock Performance and Outlook - Anterix shares have declined approximately 41.3% year-to-date, contrasting with the S&P 500's gain of 16.4% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.61 on revenues of $1.43 million, and -$0.47 on revenues of $5.71 million for the current fiscal year [7] Industry Context - The Communication - Infrastructure industry, to which Anterix belongs, is currently ranked in the top 16% of over 250 Zacks industries, suggesting a favorable industry outlook [8] - Historical data indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1, highlighting the potential for industry influence on stock performance [8]

CuriosityStream Inc. (CURI) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.06 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -200.00%. A quarter ago, it was expected that this company would post earnings of $0.01 per share when it actually produced earnings of $0.01, delivering no surprise.Over the last four quarters, the company has surp ...

Core Insights - Journey Medical Corporation reported a quarterly loss of $0.09 per share, slightly worse than the Zacks Consensus Estimate of a loss of $0.08, but an improvement from a loss of $0.12 per share a year ago, indicating a -12.50% earnings surprise [1] - The company generated revenues of $17.63 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 0.39%, but showing growth from $14.63 million in the same quarter last year [2] - Journey Medical shares have increased approximately 131.5% year-to-date, significantly outperforming the S&P 500's gain of 16.4% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.03 on revenues of $19.5 million, and for the current fiscal year, it is -$0.42 on revenues of $68.15 million [7] - The estimate revisions trend for Journey Medical was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market in the near future [6] Industry Context - The Medical - Drugs industry, to which Journey Medical belongs, is currently ranked in the top 32% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Insights - GrowGeneration (GRWG) reported a quarterly loss of $0.04 per share, better than the Zacks Consensus Estimate of a loss of $0.09, marking an earnings surprise of +55.56% [1] - The company posted revenues of $47.25 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 13.09%, although this represents a decline from $50.01 million in the same quarter last year [2] - The stock has underperformed the market, losing about 13% year-to-date compared to the S&P 500's gain of 15.6% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.08 on revenues of $39.11 million, and for the current fiscal year, it is -$0.41 on revenues of $157.56 million [7] - The estimate revisions trend for GrowGeneration was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - GrowGeneration operates within the Zacks Agriculture - Products industry, which is currently ranked in the top 41% of over 250 Zacks industries, suggesting a favorable industry outlook [8] - The performance of GrowGeneration's stock may be influenced by the overall industry trends, as empirical research indicates a strong correlation between near-term stock movements and earnings estimate revisions [5]